MSDS
COMPARE•N•SAVE
®
 CONCENTRATE  MATERIAL SAFETY DATA SHEET   
 GRASS & WEED KILLER 41% GLYPHOSATE 
  Page 4 of 6  April 29, 2010 
10. STABILITY AND REACTIVITY 
Chemical Stability: This material is stable under normal handling and storage conditions. 
Conditions to Avoid: Excessive heat. Do not store near heat or flame. 
Incompatible Materials: Strong oxidizing agents: bases and acids. This product reacts with galvanized 
steel or unlined steel (except stainless steel) to produce hydrogen gas that may form a highly combustible 
gas mixture which could flash or explode. 
Hazardous  Decomposition  Products: Under  fire  conditions,  may  produce  gases  such  as  nitrogen 
oxides, carbon oxides and phosphorous oxides. 
Hazardous Reactions: Hazardous polymerization will not occur. 
11. TOXICOLOGICAL INFORMATION 
Toxicological Data: 
Data from laboratory studies conducted on a similar, but not identical, formulation: 
Oral: Rat LD
50
: >5,000 mg/kg; FIFRA Category IV 
Dermal: Rat LD
50
: >5,000 mg/kg; FIFRA Category IV 
Inhalation: Rat 4-hr LC
50
: >2.05 mg/L; FIFRA Category IV 
Eye Irritation:  Rabbits  (6):  Moderately  irritating  (including  transient  corneal  opacity) to  unrinsed  eyes. 
Mildly  irritating  to  rinsed  eyes.  Unrinsed eyes  cleared by  day 7  and  rinsed eyes  cleared  by 72  hours; 
FIFRA Category III 
Skin Irritation: Rabbits (3); Slightly irritating. Cleared in all animals within 72 hours; FIFRA Category IV 
Skin Sensitization: Not a contact sensitizer in guinea pigs following repeated skin exposure. 
Toxicity of Isopropylamine Salt of Glyphosate: 
In repeat dosing studies (6 month), dogs fed a more concentrated form of this product exhibited slight 
body weight changes. Following repeated skin exposure (3 weeks) to this product, skin irritation was the 
primary effect in rabbits. No skin allergy was observed in guinea pigs following repeated skin exposure. 
Additional toxicity information is available on glyphosate, the active herbicidal ingredient of this product. 
Following repeated exposures (90 days) to glyphosate in their feed, decreased weight gains were noted 
at the highest test level in mice, while no treatment-related effects occurred in rats.  Following repeated 
skin exposure (3 weeks) to glyphosate, slight skin irritation was the primary effect observed in rabbits. No 
skin allergy was observed in guinea  pigs following repeated  skin exposure.  There was no  evidence  of 
effects on the nervous system, including delayed effects in chickens (repeat oral doses) or cholinesterase 
inhibition in rats (single oral  doses).  Reduced body weight gain and effects on liver  tissues were 
observed with long-term (2 year) feeding of glyphosate to mice at high-dose levels. Reduced body weight 
gain and eye changes were observed at the high-dose level in one long-term (2 year) feeding study with 
rats, while no treatment related effects occurred in a second study. No adverse effects were observed in 
feeding studies with dogs. Glyphosate did not produce tumors in any of these studies. 
Based on the results from the chronic studies, EPA has classified glyphosate in category E (evidence of 
non-carcinogenicity for humans).  No birth defects were noted in rats and rabbits given glyphosate orally 
during pregnancy, even at amounts which produced adverse effects on the mothers. Glyphosate was fed 
continuously  to  rats  at  very  high  dose  levels  for  2  successive  generations.  Toxicity  was  reported  in 
offspring from the high dose,  a level which also produced adverse effects on the  mothers. In  a 3 
generation study conducted at lower dose levels, no effects were seen on the ability of male or female 
rats  to  reproduce.  Glyphosate  has  produced  no  genetic  changes  in  a  variety  of  standard  tests  using 
animals and animal or bacterial cells. 
Toxicity of Ethoxylated Tallowamine: 
The surfactant component  of  this product is  reported to  cause  irritation to  the  eyes  and skin and may 
contribute  to  the irritation  potential  reported  for this  herbicide.  Ingestion  may  product  gastrointestinal 
irritation, nausea, vomiting and diarrhea. 






